David C. U'Prichard

David C. U'Prichard

75 year
Health Technology
Commercial Services
Finance

Profile

Dr. David C.
U'Prichard
is Independent cat Audeo Oncology, Inc., a Director at Anesiva, Inc., Founding Partner at Druid BioVentures LLC, Chairman at Cyclacel Pharmaceuticals, Inc., Venture Partner & Senior Advisor at Red Abbey Venture Partners LLC, Chairman at Orca Pharmaceuticals Ltd.
and President at Druid Consulting LLC.
He is on the Board of Directors at Audeo Oncology, Inc., iCeutica, Inc., Anesiva, Inc., Angstrom Pharmaceuticals, Inc., BioMotiv LLC, Iroko Pharmaceuticals LLC, Iroko Pharmaceuticals, Inc., Ocimum Bio Solutions (India) Ltd., Ocimum Biosolutions, Inc., International House of Philadelphia and The Wilma Theater, Inc. Dr. U'Prichard was previously employed as Independent Director by Life Technologies Corp., Chairman by Cyclacel Group Plc, Chairman by Oxagen Ltd., Chairman by Pennsylvania Biotechnology Association, Venture Partner by Apax Partners (UK) Ltd., Chief Executive Officer & Director by 3-Dimensional Pharmaceuticals, Inc., Chairman-Research & Development by Smithkline Beecham Pharmaceuticals (India) Ltd., Executive Vice President-Biomedical Research by ICI Pharmaceuticals, Director, EVP & Director-International Research by Zeneca Group Plc, Scientific Director & Senior Vice President by Nova Pharmaceutical Corp., an Associate Professor by Feinberg School of Medicine, Venture Partner by Care Capital LLC, Venture Partner by Apax Partners, Inc., and Non-Executive Director by Silence Therapeutics Plc.
He also served on the board at Alpharma, Inc., Invitrogen Corp., Biotechnology Industry Organization, Atugen AG, CoGenesys, Inc., Guilford Pharmaceuticals, Inc., Life Sciences Research, Inc., Lynx Therapeutics, Inc., Naurex, Inc., Ocimum Bio Solutions (India) Ltd., Predict, Inc. and SMART Biosciences, Inc. He received his undergraduate degree from the University of Glasgow and a doctorate degree from the University of Kansas.

Former positions of David C. U'Prichard

CompaniesPositionEnd
Churchill Pharmaceuticals Director/Board Member 2020-09-01
Director/Board Member 2020-09-01
Director/Board Member 2020-09-01
Director/Board Member 2020-09-01
International House of Philadelphia Director/Board Member 2020-09-01
See the detail of David C. U'Prichard's experience

Training of David C. U'Prichard

University of Glasgow Undergraduate Degree
University of Kansas Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David C. U'Prichard's experience

Connections

100 +

1st degree connections

49

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
SILENCE THERAPEUTICS PLC

Commercial Services

CYCLACEL PHARMACEUTICALS, INC.

Health Technology

ARIX BIOSCIENCE PLC

Finance

Private companies43

Health Technology

Health Technology

Health Technology

Finance

Electronic Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Finance

Technology Services

Alpharma, Inc. /Animal Health Division/

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Finance

Health Technology

Smithkline Beecham Pharmaceuticals (India) Ltd.

Health Technology

Druid Consulting LLC

Commercial Services

Health Technology

Health Technology

Nova Pharmaceutical Corp.

Commercial Services

Health Technology

Commercial Services

International House of Philadelphia

Consumer Services

Health Technology

Finance

Technology Services

Churchill Pharmaceuticals

See company connections
  1. Stock
  2. Insiders
  3. David C. U'Prichard